Brian Goodman, CEO of Golden Matrix Group Inc. explains how they stay one step ahead of their rivals. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.20 (13.333%)
Open: 1.60
High: 1.60
Low: 1.60
Prev. Close: 1.60

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares & TVR

19 Feb 2024 07:00

RNS Number : 5212D
Seed Innovations Limited
19 February 2024
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

19 February 2024

SEED Innovations Limited

("SEED" or the "Company")

Transaction in Own Shares & TVR

SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, announces that it has purchased the following number of its shares of 1p each on the London Stock Exchange to be held in treasury (through Shard Capital Stockbrokers Limited ("Shard") acting as the Company's broker).

Date of Purchase

16 February 2024

Number of shares purchased (aggregated volume):

118,000

Highest price paid per share (pence):

2.19 pence

Lowest price paid per share (pence):

2.19 pence

Volume weighted average price paid per share (pence):

2.19 pence

 

Following the purchase of these shares, the Company's issued ordinary share capital consists of 215,219,841 ordinary shares of which a total of 12,399,446 shares are held in treasury. The remaining 202,820,395 shares represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Shard on 16 February 2024 as part of the Programme as defined by the Company in the announcement on 29 September 2023.

Aggregate information: 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

AIMX

2.19

118,000

 

 

 

 

 

 

 

Individual transactions:

Number of shares purchased

Transaction price(pence per share)

Time of transaction

Venue

118,000

2.19

16.18.49

AIMX

 

-Ends-

For further information on the Company please visit: www.seedinnovations.co or contact: 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co 

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Ana Ribeiro

Isabelle Morris

 

St Brides Partners Ltd,

Financial PR

E: seed@stbridespartners.co.uk

Notes

Seed Innovations Ltd

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKFBDABKDQBD
Date   Source Headline
28th Nov 20239:00 amRNSTransaction in Own Shares & TVR
24th Nov 20237:00 amRNSTransaction in Own Shares & TVR
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20232:29 pmRNSInterim Results
20th Nov 202310:18 amRNSInvestee Company Update: Little Green Pharma Ltd
20th Nov 20237:00 amRNSTransaction in Own Shares & TVR
15th Nov 20231:47 pmRNSTransaction in Own Shares & TVR
15th Nov 20237:00 amRNSTransaction in Own Shares & TVR
14th Nov 20237:00 amRNSTransaction in Own Shares & TVR
13th Nov 20231:01 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Nov 20237:00 amRNSTransaction in Own Shares & TVR
3rd Nov 20237:05 amRNSTransaction in Own Shares & TVR
2nd Nov 20231:16 pmRNSTransaction in Own Shares & TVR
2nd Nov 202311:42 amRNSHolding(s) in Company
31st Oct 202311:27 amRNSInvestee Company Update: Little Green Pharma Ltd
30th Oct 20237:00 amRNSIn-person Shareholder Event in London
27th Oct 20237:00 amRNSTransaction in Own Shares & TVR
24th Oct 202312:30 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSTransaction in Own Shares & TVR
23rd Oct 20237:00 amRNSTransaction in Own Shares & TVR
20th Oct 20237:00 amRNSTransaction in Own Shares & TVR
19th Oct 20237:00 amRNSTransaction in Own Shares & TVR
18th Oct 20237:00 amRNSTransaction in Own Shares & TVR
17th Oct 20237:00 amRNSTransaction in Own Shares & TVR
16th Oct 20237:00 amRNSTransaction in Own Shares & TVR
13th Oct 202312:01 pmRNSTransaction in Own Shares & TVR
12th Oct 20237:00 amRNSTransaction in Own Shares & TVR
11th Oct 20237:00 amRNSTransaction in Own Shares & TVR
10th Oct 202311:37 amRNSTransaction in Own Shares & TVR
9th Oct 20237:00 amRNSTransaction in Own Shares & TVR
6th Oct 20238:06 amRNSTransaction in Own Shares & TVR
5th Oct 20235:23 pmRNSTransaction in Own Shares & TVR
4th Oct 20237:00 amRNSTransaction in Own Shares & TVR
3rd Oct 20233:40 pmRNSTransaction in Own Shares & TVR
20th Sep 202311:00 amRNSResult of AGM
19th Sep 20236:00 pmRNSShare Buy-Back Programme
13th Sep 20235:34 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSPartial Sale of Avextra:60% Premium to Entry Point
8th Sep 202312:15 pmRNSInvestee Company Updates: Northern Leaf & OTO
7th Sep 202310:40 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Sep 20237:01 amRNSNotice of AGM & Investor Presentation
1st Sep 20237:00 amRNSAppointment of Executive Director
16th Aug 202311:00 amRNSInvestee Company Update: Little Green Pharma Ltd
14th Aug 20237:15 amRNSInvestee Company Update: Clean Food Group
8th Aug 20237:00 amRNSClean Food Group Update: Strategic Collaboration
3rd Aug 20237:00 amRNSInvestee Company Update: Portage Biotech Inc
3rd Aug 20237:00 amRNSInvestee Company Update: Little Green Pharma Ltd
28th Jul 20231:46 pmRNSInvestee Company Update: Little Green Pharma Ltd
12th Jul 20231:10 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Jun 20232:38 pmRNSInvestee Company Update: Little Green Pharma Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.